Deze website maakt gebruik van cookies. We gebruiken cookies om instellingen te onthouden en je bezoek soepeler te laten verlopen. Daarnaast gebruiken we ook cookies voor de verbetering van de website en het verzamelen en analyseren van statistieken. Lees meer over cookies

Home
Lindy Vernooij

Lindy Vernooij

PhD Student

Molenaar groep

Lindy is PhD student binnen de Molenaar groep.

Phone

Email L.Vernooij-4@prinsesmaximacentrum.nl

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma
- jan. 2023
- Thomas F, Eleveld, et al
- Frontiers in Oncology
High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells
- jun. 2021
- Lindy, Vernooij, et al
- Molecular Cancer Therapeutics
Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses
- jan. 2021
- Nil A., Schubert, et al
- European Journal of Cancer

Bekijk alle publicaties

Lindy Vernooij

Publicaties

MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma

High-throughput screening identifies idasanutlin as a resensitizing drug for venetoclax-resistant neuroblastoma cells

Combined targeting of the p53 and pRb pathway in neuroblastoma does not lead to synergistic responses